Loading company…
Pleryon Pharmaceutics develops ophthalmic drugs and drug delivery platforms.
Founded in 2016 and based in Shenzhen, China, Pleryon Pharmaceutics develops ophthalmic drugs and drug delivery technologies. Its pipeline includes a contact lens lubricant and a long-acting anti-VEGF gel, alongside platforms for sustained release, polymer drugs, and nucleic acid delivery. In August 2025, it raised Series A funding from Efung Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in